Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


Issue 14, 2020
Previous Article Next Article

Platinum-loaded, selenium-doped hydroxyapatite nanoparticles selectively reduce proliferation of prostate and breast cancer cells co-cultured in the presence of stem cells

Author affiliations

Abstract

Chemotherapeutic treatment of patients with bone tumors or bone metastases often leads to severe side effects such as high drug toxicity, lack of tumor specificity and induced drug resistance. A novel strategy to treat early stages of bone metastases involves local co-delivery of multiple chemotherapeutic agents to synergistically improve the curative effect and overcome shortcomings of traditional chemotherapy. Herein we show that selenite-doped hydroxyapatite nanoparticles loaded with a hydroxyapatite-binding anti-tumor platinum complex (PtPP–HASe) selectively reduce proliferation of cancer cells without reducing proliferation of bone marrow stem cells. These PtPP–HASe particles were nanocrystalline with selenium (Se) and platinum (Pt) contents ranging between 0–10 and 1.5–3 wt%, respectively. Release kinetics of Se and Pt from PtPP–HASe nanoparticles resulted in a cumulative release of ∼10 and ∼66 wt% after 7 days, respectively. At a Pt/Se ratio of 8, released Pt and Se species selectively reduced cell number of human prostate (PC3) and human breast cancer cells (MDA-MB-231) by a factor of >10 with limited effects on co-cultured human bone marrow stem cells (hBMSc). These novel nanoparticles demonstrate high anti-cancer selectivity, which offers ample opportunities for the design of novel biomaterials with potent and selective chemotherapeutic efficacy against cancer cells.

Graphical abstract: Platinum-loaded, selenium-doped hydroxyapatite nanoparticles selectively reduce proliferation of prostate and breast cancer cells co-cultured in the presence of stem cells

Back to tab navigation

Supplementary files

Article information


Submitted
12 Feb 2020
Accepted
04 Mar 2020
First published
05 Mar 2020

J. Mater. Chem. B, 2020,8, 2792-2804
Article type
Paper

Platinum-loaded, selenium-doped hydroxyapatite nanoparticles selectively reduce proliferation of prostate and breast cancer cells co-cultured in the presence of stem cells

A. Barbanente, R. A. Nadar, L. D. Esposti, B. Palazzo, M. Iafisco, J. J. J. P. van den Beucken, S. C. G. Leeuwenburgh and N. Margiotta, J. Mater. Chem. B, 2020, 8, 2792
DOI: 10.1039/D0TB00390E

Social activity

Search articles by author

Spotlight

Advertisements